These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37195184)

  • 1. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
    Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
    Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for Pneumocystis jirovecii pneumonia after kidney transplantation: A systematic review and meta-analysis.
    Cheng B; Qi C; Zhang S; Wang X
    Clin Transplant; 2024 May; 38(5):e15320. PubMed ID: 38690617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
    Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
    BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.
    Permpalung N; Kittipibul V; Mekraksakit P; Rattanawong P; Nematollahi S; Zhang SX; Steinke SM
    Transplantation; 2021 Oct; 105(10):2291-2306. PubMed ID: 33323766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
    Brakemeier S; Dürr M; Bachmann F; Schmidt D; Gaedeke J; Budde K
    Transplant Proc; 2016 Nov; 48(9):2924-2930. PubMed ID: 27932109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers.
    Paulsen G; Michaels MG; Danziger-Isakov L; Dipchand AI; Green M; McCulloch M
    Pediatr Transplant; 2020 Feb; 24(1):e13609. PubMed ID: 31713958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Shokoohi M; Singh G; Dufresne SF; Boucher A; Jevnikar A; Prasad GVR; Shoker A; Kabbani D; Hebert MJ; Cardinal H; Houde I; Humar A; Kumar D
    Clin Infect Dis; 2019 Apr; 68(8):1320-1326. PubMed ID: 30107568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of predictive markers of Pneumocystis jirovecii pneumonia in kidney transplant recipients.
    Zhou J; Pan H; Zhang J; Luo L; Cao Y; Wang L; Cheng Z; Zhang G
    Transpl Immunol; 2024 Aug; 85():102074. PubMed ID: 38945175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
    Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW
    Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study.
    Lee G; Koo TY; Kim HW; Lee DR; Lee DW; Oh J; Kim BS; Kim MS; Yang J;
    Sci Rep; 2022 Jun; 12(1):10682. PubMed ID: 35739203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients.
    Veronese G; Ammirati E; Moioli MC; Baldan R; Orcese CA; De Rezende G; Veronese S; Masciocco G; Perna E; Travi G; Puoti M; Cipriani M; Tiberi S; Cirillo D; Frigerio M
    Transpl Infect Dis; 2018 Jun; 20(3):e12880. PubMed ID: 29514393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
    Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
    Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
    Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
    Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and risk factors for late-onset pneumocystis jirovecii pneumonia in kidney transplantation recipients.
    Zhu X; Xie M; Fan J; Geng B; Fei G; Zhou Q; Wu H; Liu X; Jiang X
    Mycoses; 2024 Jan; 67(1):e13688. PubMed ID: 38214337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient.
    Yau AA; Farouk SS
    BMC Infect Dis; 2019 Aug; 19(1):739. PubMed ID: 31438872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
    Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.